Schear Investment Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Schear Investment Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-915	Closed	-$455K	–	93
2025 Q1	$455K	Sell	915 -86	-9%	-$46.6K	0.26%	73
2024 Q4	$521K	Sell	1,001 -164	-14%	-$90.2K	0.28%	71
2024 Q3	$721K	Buy	1,165 +96	+9%	+$56.8K	0.45%	68
2024 Q2	$591K	Sell	1,069 -6	-0.6%	-$3.44K	0.43%	66
2024 Q1	$625K	Buy	1,075 +6	+0.6%	+$3.37K	0.5%	63
2023 Q4	$567K	Sell	1,069 -7	-0.7%	-$3.39K	0.55%	52
2023 Q3	$545K	Sell	1,076 -103	-9%	-$54.9K	0.59%	52
2023 Q2	$615K	Buy	1,179 +47	+4%	+$25.4K	0.65%	53
2023 Q1	$652K	Buy	1,132 +272	+32%	+$153K	0.78%	47
2022 Q4	$474K	Buy	+860	New	+$456K	0.58%	59

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Schear Investment Advisers's TMO Position: Q2 2025 in Review

Schear Investment Advisers sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 915 shares — an estimated $455K sold.

Schear Investment Advisers first reported a position in TMO in Q4 2022 and held it in 10 quarters. The position peaked at $721K in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Schear Investment Advisers reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Schear Investment Advisers sold 915 Thermo Fisher Scientific shares in Q2 2025, an estimated $455K.
Schear Investment Advisers first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 10 quarters.
Schear Investment Advisers's Thermo Fisher Scientific position peaked at $721K in Q3 2024.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Schear Investment Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.